Closing

Do GLP-1 receptor agonists improve lipids versus placebo?

Mostly studied in type 2 & unspecified diabetes. Also asked against other treatments.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

A coin flip. So far, one result, not yet repeated.

NoUnsureYes
Belief
0.50 (range 0.25–0.70)
Trials for
1
Trials against
0
Inconclusive
9

Already under way

The evidence so far

Registered trials
297
With posted results
96
Published papers
5

Of 45 decided analyses: 12 favor glp-1 receptor agonists, 31 find no difference, 2 favor the comparator.

Papers

Trials

See every trial in the evidence map →